Cargando…
Thiopurine Drugs Repositioned as Tyrosinase Inhibitors
Drug repositioning is the application of the existing drugs to new uses and has the potential to reduce the time and cost required for the typical drug discovery process. In this study, we repositioned thiopurine drugs used for the treatment of acute leukaemia as new tyrosinase inhibitors. Tyrosinas...
Autores principales: | Choi, Joonhyeok, Lee, You-Mie, Jee, Jun-Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796027/ https://www.ncbi.nlm.nih.gov/pubmed/29283382 http://dx.doi.org/10.3390/ijms19010077 |
Ejemplares similares
-
Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors
por: Choi, Joonhyeok, et al.
Publicado: (2015) -
New Inhibitors of Laccase and Tyrosinase by Examination of Cross-Inhibition between Copper-Containing Enzymes
por: Chaudhary, Dinesh, et al.
Publicado: (2021) -
Hydroxamic Acid as a Potent Metal-Binding Group for Inhibiting Tyrosinase
por: Choi, Joonhyeok, et al.
Publicado: (2022) -
Antithrombotic properties of JJ1, a potent and novel thrombin inhibitor
por: Lee, Wonhwa, et al.
Publicado: (2017) -
Assessment of Thiopurine–based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia
por: Azimi, F, et al.
Publicado: (2014)